[Pharmacological properties of pyrazolone and pyrazolidine derivatives (review of the literature)].
D000632:Aminopyrine / Q000494:pharmacology*; D000707:Anaphylaxis / Q000517:prevention & control; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D004177:Dipyrone / Q000494:pharmacology; D005340:Fibrinogen / Q000096:biosynthesis; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D007705:Kinins / Q000037:antagonists & inhibitors; D010653:Phenylbutazone / Q000009:adverse effects / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000096:biosynthesis; D012216:Rheumatic Diseases / Q000188:drug therapy; D013276:Stomach Ulcer / Q000139:chemically induced; D014535:Uridine Diphosphate Glucuronic Acid / Q000096:biosynthesis
D000893:Anti-Inflammatory Agents; D007705:Kinins; D011458:Prostaglandins E; D000632:Aminopyrine; D014535:Uridine Diphosphate Glucuronic Acid; D004177:Dipyrone; D005340:Fibrinogen; D010653:Phenylbutazone
Farmakologicheskie svoĭstva proizvodnykh pirazolona i pirazolidina (obzor literatury).